Buchumschlag

Association of Influenza Vaccination During Pregnancy with Health Outcomes in Mothers and Children: A Population‐Based Cohort Study

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Hyesung Lee, Dongwon Yoon, Ju Hwan Kim, Yunha Noh, Eun‐Jeong Joo, Jung Yeol Han, Young June Choe, Ju‐Young Shin
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Clinical Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Selected Acute Safety Events Following the Use of Nirmatrelvir/Ritonavir or Molnupiravir for COVID‐19: A Nationwide Cohort Study in South Korea
von: Ju Hwan Kim, et al.
Veröffentlicht: (2024)

Tenofovir Alafenamide Therapy Throughout Pregnancy in Mothers With Hepatitis B
von: Xingfei Pan, et al.
Veröffentlicht: (2025)

Population Pharmacokinetic and Exposure‐Efficacy Analysis of Baloxavir Marboxil for Influenza Treatment and Post‐Exposure Prophylaxis in Children
von: Sylvie Retout, et al.
Veröffentlicht: (2026)

Clinical Course and Prognosis of Long‐Term Survivors of Hepatocellular Carcinoma
von: Soon Sun Kim, et al.
Veröffentlicht: (2025)

P‐ CAB vs. PPI for Upper Gastrointestinal Bleeding Prevention in Patients With Atherothrombotic Disease on Antithrombotic Therapy: A CDM Cohort Study
von: Min Joo Yoon, et al.
Veröffentlicht: (2026)

Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin in Black Rockfish ( Sebastes schlegelii ) Following a Single Oral Administration at Two Water Temperatures
von: Jun Sung Bae, et al.
Veröffentlicht: (2025)

Populations Addressed in Vaccines Approved via the European Medicines Agency
von: Débora D. Gräf, et al.
Veröffentlicht: (2025)

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation
von: Hyun Woong Park, et al.
Veröffentlicht: (2025)

Risk Prediction of Early‐Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult Cohort
von: Seogsong Jeong, et al.
Veröffentlicht: (2026)

BCR::ABL1 Tyrosine Kinase Inhibitors During Pregnancy, a Disproportionality Analysis of Vigibase
von: Aurélie Cabannes‐Hamy, et al.
Veröffentlicht: (2025)

Risk of Variceal Bleeding in Patients Receiving Atezolizumab–Bevacizumab Treatment for Hepatocellular Carcinoma
von: Kanghee Park, et al.
Veröffentlicht: (2025)

Changes in S‐Citalopram Plasma Concentrations Across Pregnancy and Postpartum
von: Catherine S. Stika, et al.
Veröffentlicht: (2025)

Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study
von: Teng‐Li Lin, et al.
Veröffentlicht: (2026)

Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic Esophagitis
von: Jenny‐Hoa Nguyen, et al.
Veröffentlicht: (2026)

Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model
von: Miramar Sami Kardouh, et al.
Veröffentlicht: (2025)

Editorial: Prevention of Upper GI Bleeding in Users of Anti‐Thrombotic Drugs—P‐ CABs Versus PPIs . Authors' Reply
von: Min Joo Yoon, et al.
Veröffentlicht: (2026)

Editorial: Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Prior to Liver Transplantation—Current Evidence and Future Directions
von: Mohammad Saeid Rezaee‐Zavareh, et al.
Veröffentlicht: (2026)

Meta‐Analysis: Pregnancies With Inflammatory Bowel Disease Complicated by Intrahepatic Cholestasis of Pregnancy
von: Shamim Joudaki, et al.
Veröffentlicht: (2025)

Application of clinical decision support tools for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicentre study
von: Kyuwon Kim, et al.
Veröffentlicht: (2024)

Developing and Refining the Pregnancy Algorithm CErtaInty Tool ( ACE ‐ IT ) for Validating Pregnancy Outcomes
von: Sonal Singh, et al.
Veröffentlicht: (2025)

Population Time‐to‐Event Modeling of Pregnancy Loss Risk Following Frozen Embryo Transfer: A Real‐World Study in Chinese Women
von: Wen Yao Mak, et al.
Veröffentlicht: (2025)

Effectiveness and Safety of Reduced‐Dose Prasugrel in an East Asian Population: PRASFIT ‐ ACS Emulation Using National Health Insurance Claims Data
von: Li‐Wen Huang, et al.
Veröffentlicht: (2025)

Women's Health Disorders in a Coeliac Disease Population After Diagnosis—A Nationwide Cohort Analysis
von: Rama Nanah, et al.
Veröffentlicht: (2025)

Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable Bowel Syndrome
von: Andrea Shin, et al.
Veröffentlicht: (2025)

Assessing Post‐Marketing Requirements for Orphan Drugs: A Cross‐Sectional Analysis of FDA and EMA Oversight
von: Jae Hyeon Yu, et al.
Veröffentlicht: (2024)

Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit /Hyperactivity Disorder
von: Shen Cheng, et al.
Veröffentlicht: (2024)

Pain and Sedative Medication Use Among Individuals With Inflammatory Bowel Disease: A Nationwide Population‐Based Cohort Study
von: Samantha Baillie, et al.
Veröffentlicht: (2025)

Editorial: Flipping the Script—Higher Risk of Hepatocellular Carcinoma With Tenofovir Compared to Entecavir in a French Population‐Based Cohort
von: Ariel Lee, et al.
Veröffentlicht: (2025)

Comparative Effectiveness of First‐Line Pembrolizumab vs. Chemotherapy in aNSCLC : A Norwegian Population‐Based Cohort Study
von: Simon Boge Brant, et al.
Veröffentlicht: (2025)

Correction to “Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit/Hyperactivity Disorder”
Veröffentlicht: (2025)

Late Diagnosis of Chronic Hepatitis B in the United States: A Population‐Based, Retrospective Cohort Study From 2007 to 2021
von: Michael H. Le, et al.
Veröffentlicht: (2025)

Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling
von: Sejung Hwang, et al.
Veröffentlicht: (2024)

Letter: Crohn's Disease or Comorbidity? Reassessing Opioid Prescribing Patterns
von: Kuan‐Ju Lin, et al.
Veröffentlicht: (2025)

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination
von: Yash Hegde, et al.
Veröffentlicht: (2026)

Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): A Population‐Based Cohort Study
von: Yee Hui Yeo, et al.
Veröffentlicht: (2025)

Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study
von: Noémie de Cacqueray, et al.
Veröffentlicht: (2026)

Population Pharmacokinetics and Exposure–Response Analysis of a Fixed‐Dose Combination of Ivermectin and Albendazole in Children, Adolescents, and Adults
von: Jaime Algorta, et al.
Veröffentlicht: (2024)

Higher Prescribed Opioid Use Among Adults With Crohn's Disease Than General Population: A Nationwide Cohort Study in Sweden 2006–2021
von: Mehdi Osooli, et al.
Veröffentlicht: (2025)

Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population‐Based Cohort Study Using Antibiotic Dispensing Data
von: Maria J. Alfonso Arvez, et al.
Veröffentlicht: (2025)

Letter: Optimising Hepatitis B Vaccination in Inflammatory Bowel Disease – Expanding Strategies Beyond Double‐Dose Recombinant Vaccination. Authors' Reply
von: Anupam Kumar Singh, et al.
Veröffentlicht: (2026)